What are the appropriate antibiotic choices and dosing for an adult with end‑stage renal disease on dialysis who presents with a urinary tract infection?

Antibiotic Selection and Dosing for UTI in ESRD Patients on Dialysis

First-Line Recommendation

For adults with end-stage renal disease on dialysis who present with a urinary tract infection, use ciprofloxacin 250–500 mg orally every 24 hours, administered immediately after each dialysis session. 1, 2

---

Fluoroquinolones: Preferred First-Line Agents

Fluoroquinolones remain the preferred antibiotics for ESRD patients with UTI because they maintain excellent urinary concentrations and require only interval extension rather than dose reduction, preserving their concentration-dependent bactericidal activity. 1

Ciprofloxacin Dosing for Hemodialysis

• Give 250–500 mg orally every 24 hours, dosed immediately after dialysis sessions 1, 2
• The FDA label confirms this regimen for patients on hemodialysis or peritoneal dialysis 2
• Avoid twice-daily dosing (the usual 500 mg every 12 hours used in normal renal function is inappropriate for dialysis patients) 3
• Interval prolongation (500 mg every 24 hours) is pharmacodynamically superior to dose reduction (250 mg every 12 hours) for the same total daily amount 3

Levofloxacin as an Alternative

• For patients with creatinine clearance <50 mL/min who prefer once-daily dosing: give a 500 mg loading dose, then 250 mg every 48 hours post-dialysis 1
• Do not extrapolate ciprofloxacin dosing from levofloxacin, as they require different adjustments 3

Treatment Duration

• Treat for 7 days for uncomplicated cystitis 1, 3
• For complicated UTI or pyelonephritis: 7–14 days 1

---

Alternative Agents When Fluoroquinolones Are Contraindicated

Trimethoprim-Sulfamethoxazole

• For ESRD or creatinine clearance <30 mL/min: use half the standard dose (1 single-strength tablet daily) or select an alternative agent 4, 1
• This agent should be avoided when local resistance exceeds 20% 1

Beta-Lactams for Complicated UTI

For hospitalized patients requiring parenteral therapy: 1

• Ceftriaxone 1–2 g IV every 24 hours (no renal dose adjustment needed)
• Cefepime 1–2 g IV every 12 hours (requires dose adjustment)
• Piperacillin/tazobactam 2.5–4.5 g IV every 8 hours (requires dose adjustment)

---

Critical Dosing Principles for ESRD

Interval Extension vs. Dose Reduction

For concentration-dependent antibiotics (fluoroquinolones, aminoglycosides), extend the dosing interval rather than reduce the dose to maintain peak bactericidal activity. 4, 1

• Smaller doses significantly reduce efficacy of concentration-dependent antibiotics 1
• This principle is consistently emphasized across KDOQI, IDSA, and CDC guidance 4, 1

Post-Dialysis Administration

Always administer antibiotics after hemodialysis to prevent drug removal during dialysis and facilitate directly observed therapy. 1, 5

---

Agents to Avoid in ESRD

Aminoglycosides

Avoid aminoglycosides in CKD/ESRD patients due to nephrotoxicity risk, except for single-dose therapy in simple cystitis. 4, 1

• If aminoglycosides must be used: reduce dose and/or increase dosage interval when GFR <60 mL/min, monitor serum levels (trough and peak), and avoid concomitant ototoxic agents such as furosemide 4

Nitrofurantoin

Do not use nitrofurantoin in ESRD due to insufficient efficacy data in renal impairment and high risk of peripheral neuritis. 1

Tetracyclines

Reduce dose when GFR <45 mL/min; tetracyclines can exacerbate uremia 4

---

Multidrug-Resistant Organisms

For ESBL-Producing Organisms

Use carbapenems or ceftazidime-avibactam 2.5 g IV every 8 hours with renal dose adjustment 1

For Carbapenem-Resistant Enterobacterales (CRE)

Use ceftazidime-avibactam 2.5 g IV every 8 hours, with dose adjustment based on renal function 1

---

Common Pitfalls to Avoid

• Never assume normal dosing based on "normal" serum creatinine alone, especially in elderly patients or those with reduced muscle mass, as this masks severe renal impairment 3
• Do not reduce aminoglycoside doses; instead extend intervals to maintain concentration-dependent killing 1
• Monitor for drug accumulation even with hepatically-metabolized drugs, as renal failure increases toxicity risk through altered metabolism 1
• Avoid fluoroquinolones in elderly patients with renal failure when possible due to increased risk of tendon disorders, especially with concomitant corticosteroid therapy 1
• The FDA issued an advisory in 2016 warning that fluoroquinolones should not be used for uncomplicated UTIs due to disabling adverse effects, though they remain appropriate for complicated UTI and pyelonephritis in renal impairment 1

---

Special Considerations

Polycystic Kidney Disease

For suspected cyst infection in patients with polycystic kidney disease, use lipid-soluble antibiotics such as trimethoprim-sulfamethoxazole or fluoroquinolones, as they penetrate cysts better. 1

• Treatment duration for confirmed kidney cyst infection should be 4–6 weeks 1

Peritoneal Dialysis

The same ciprofloxacin dosing applies: 250–500 mg every 24 hours after dialysis 2